在刚果民主共和国伊图里地区爆发的埃博拉疫情中，一项旨在测试两种药物的临床试验已正式启动 [1]。该研究仅在世界卫生组织于5月17日宣布将此次疫情列为国际关注的突发公共卫生事件后的六周内完成筹备并招募到首批受试者，创下了此类试验的最快记录 [1]。
The first phase of a clinical trial for an experimental Ebola vaccine has begun in the Ituri region of the Democratic Republic of Congo, where an outbreak is currently underway [1]. This recruitment effort was completed within six weeks following the World Health Organization's declaration on May 17 that the situation constituted a Public Health Emergency of International Concern (PHEIC) [1]. The speed at which these initial patients were enrolled sets a new record for such research initiatives in this context [1]. Two different drugs are currently being tested as part of this trial protocol [1].